Genapsys is a series c plus startup based in United States. 3 investors tracked. Status: zombie.
Genapsys is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Genapsys develops a highly accurate, scalable, and affordable DNA sequencing platform for various applications in research and diagnostics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.